Copyright Reports & Markets. All rights reserved.

Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 CINV
    • 1.4.3 PONV
  • 1.5 Market by Application
    • 1.5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Ambulatory Surgical Centers
    • 1.5.4 Diagnostic Centers
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Perspective (2015-2026)
  • 2.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Trends by Regions
    • 2.2.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Chemotherapy-Induced Nausea and Vomiting (CINV) Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Market Size
    • 3.1.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue (2015-2020)
    • 3.1.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio
    • 3.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2019
  • 3.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players Head office and Area Served
  • 3.4 Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
  • 3.5 Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Type (2015-2020)
  • 4.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)
  • 5.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
  • 6.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in North America (2019-2020)
  • 6.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
  • 6.4 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
  • 7.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Europe (2019-2020)
  • 7.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
  • 7.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

8 China

  • 8.1 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
  • 8.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in China (2019-2020)
  • 8.3 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
  • 8.4 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
  • 9.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Japan (2019-2020)
  • 9.3 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
  • 9.4 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
  • 10.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

11 India

  • 11.1 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
  • 11.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in India (2019-2020)
  • 11.3 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
  • 11.4 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
  • 12.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
  • 12.4 Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Merck
    • 13.1.1 Merck Company Details
    • 13.1.2 Merck Business Overview
    • 13.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 13.1.4 Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020))
    • 13.1.5 Merck Recent Development
  • 13.2 Eisai
    • 13.2.1 Eisai Company Details
    • 13.2.2 Eisai Business Overview
    • 13.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 13.2.4 Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 13.2.5 Eisai Recent Development
  • 13.3 ProStrakan
    • 13.3.1 ProStrakan Company Details
    • 13.3.2 ProStrakan Business Overview
    • 13.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 13.3.4 ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 13.3.5 ProStrakan Recent Development
  • 13.4 Helsinn Holding
    • 13.4.1 Helsinn Holding Company Details
    • 13.4.2 Helsinn Holding Business Overview
    • 13.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 13.4.4 Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 13.4.5 Helsinn Holding Recent Development
  • 13.5 Mundipharma
    • 13.5.1 Mundipharma Company Details
    • 13.5.2 Mundipharma Business Overview
    • 13.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 13.5.4 Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 13.5.5 Mundipharma Recent Development
  • 13.6 Qilu Pharma
    • 13.6.1 Qilu Pharma Company Details
    • 13.6.2 Qilu Pharma Business Overview
    • 13.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 13.6.4 Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 13.6.5 Qilu Pharma Recent Development
  • 13.7 Teva
    • 13.7.1 Teva Company Details
    • 13.7.2 Teva Business Overview
    • 13.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 13.7.4 Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 13.7.5 Teva Recent Development
  • 13.8 Novartis
    • 13.8.1 Novartis Company Details
    • 13.8.2 Novartis Business Overview
    • 13.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 13.8.4 Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 13.8.5 Novartis Recent Development
  • 13.9 Heron Therapeutics
    • 13.9.1 Heron Therapeutics Company Details
    • 13.9.2 Heron Therapeutics Business Overview
    • 13.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 13.9.4 Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 13.9.5 Heron Therapeutics Recent Development
  • 13.10 Roche
    • 13.10.1 Roche Company Details
    • 13.10.2 Roche Business Overview
    • 13.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 13.10.4 Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 13.10.5 Roche Recent Development
  • 13.11 Mylan
    • 10.11.1 Mylan Company Details
    • 10.11.2 Mylan Business Overview
    • 10.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 10.11.4 Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 10.11.5 Mylan Recent Development
  • 13.12 Tesaro
    • 10.12.1 Tesaro Company Details
    • 10.12.2 Tesaro Business Overview
    • 10.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
    • 10.12.4 Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
    • 10.12.5 Tesaro Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Chemotherapy-Induced Nausea and Vomiting (CINV) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy-Induced Nausea and Vomiting (CINV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Merck
    Eisai
    ProStrakan
    Helsinn Holding
    Mundipharma
    Qilu Pharma
    Teva
    Novartis
    Heron Therapeutics
    Roche
    Mylan
    Tesaro

    Market segment by Type, the product can be split into
    CINV
    PONV
    Market segment by Application, split into
    Hospitals
    Ambulatory Surgical Centers
    Diagnostic Centers

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now